Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
We're at an incredible new frontier in neuroscience, where we have this deep understanding of the causal drivers of neurodegenerative and psychiatric diseases.
Simplified Text
Neuroscience is at new frontier with deep understanding of causal drivers of neurodegenerative psychiatric diseases
Confidence Score
0.500
Claim Maker
K. Rhodes
Context Type
Website Article
Context Details
{
    "date": null
}
Subject Tags
UUID
9fc8a1ab-43d3-4e77-bfc9-3de3a9d40412
Vector Index
✗ No vector
Created
September 2, 2025 at 7:15 PM (1 week ago)
Last Updated
September 2, 2025 at 7:15 PM (1 week ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://www.bms.com/life-and-science/science/renaissance-neuroscience-research-development.html?cid=d_3267515&dclid=CN-sjNPAsI8DFazArQAd_vguSA&gad_source=7
37 claims 🔥
1 week ago
https://www.bms.com/life-and-science/science/renaissance-neuroscience-research-development.html?cid=d_3267515&dclid=CN-sjNPAsI8DFazArQAd_vguSA&gad_source=7

Bristol Myers Squibb is accelerating neuroscience R&D using breakthroughs in human biology, biomarkers, and computational science to improve outcomes for patients with neurological conditions. The company is exploring new approaches to slow disease progression and alleviate symptoms.

Neuroscience
Research and Development
Biomarkers
Neurodegenerative Diseases
Neuropsychiatric Disorders
Pharmaceutical Industry
Bristol Myers Squibb

Similar Claims (0)

Other claims identified as semantically similar to this one.

No similar claims found

This claim appears to be unique in the system.

Claim Management System - MVP